Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for post-traumatic stress and clinical outcomes in burn inpatients
IRCT20190919044819N2Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of propranolol in burn injury and post-traumatic stress disorder (PTSD) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Post-traumatic stress, Hemoglobin and 3 more. Started Aug 2020; status: completed.
02
Drugs
propranolol
03
Conditions
burn injurypost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on IRCT20190919044819N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190919044819N2.